Cite
MLA Citation
David A. Reardon et al.. “Phase I/randomized phase II study of afatinib, an irreversible ErbB family blocker, with or without protracted temozolomide in adults with recurrent glioblastoma.” Neuro-oncology, vol. 17, no. 3, n.d., pp. 430–439. http://access.bl.uk/ark:/81055/vdc_100173694980.0x000017